The McCune-Albright syndrome: Clinical and therapeutic observations;La sindrome di McCune-Albright: Osservazioni cliniche e terapeutiche

Rivista Italiana di Pediatria

Volumn 23, Issue 1, 1997, Pages 25-32

  Lala, R ^a   Matarazzo, P ^a   Sciolla, A ^b   Picciotto, G ^c   De Sanctis, C ^a  

^a REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

Author keywords

autonomous cell hyperfunction; cafe au lait spots; polyostotic fibrous dysplasia; precocious puberty

Indexed keywords

PAMIDRONIC ACID; TESTOLACTONE;

ALBRIGHT SYNDROME; ARTICLE; BONE DYSPLASIA; CAFE AU LAIT SPOT; CLINICAL ARTICLE; FEMALE; HUMAN; INFANT; MALE; PRECOCIOUS PUBERTY; PRESCHOOL CHILD; SCHOOL CHILD;

EID: 0030976121     PISSN: 03925161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Albright F. Polyostotic fibrous dysplasia: a defense of the entity. J Clin Endocrinol Metab 1947;7:307.
2. Mauras M, Blizzard RM. The McCune-Albright syndrome. Acta Endocrinol 1986;113 (suppl.279):207.
3. Danon M, Crawford JD. The McCune-Albright syndrome. Ergeb Inn Med Kinderheilk 1987;55:81.
4. Shenker A, Weinstein LS, Moran A, Pescovitz OH, Carest NJ. Severe endocrine and nonendocrine manifest,ations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein Gs. J Pediatr 1993;123:509.
5. Comite F, Shawker TH, Pecowitz OH, Loriaux DL, Cutler GB. Cyclical ovarian function resistant to treatment with an analogue of luteinizing hormone releasing hormone in McCune-Albright syndrome. N Engl J Med 1984;311:1032.
6. Feuillan PP, Shawker T, Rose SR, Jones J, Jeevanram RK, Nisula BC. Thyroid abnormalities in the McCune-Albright syndrome: ultra sonography and hormonal studies. J Clin Endocrinol Metab 1990;71:1596.
7. Danon M, Robboy SJ, Kim S, Scully R, Crawford JD. Cushing syndrome, sexual precocity, and polyostotic fibrous dysplasia (Albright syndrome) in infancy. J Pediatr 1975;87:917.
8. Cremonini N, Graziano E, Chiarini V, Sforza A, Zampa GA. Atypical McCune-Albright syndrome associated with growth hormone-prolactin pituitary adenoma: natural history, long-term follow-up, and SMS 201-995-Bromocriptine combined treatment results. J Clin Endocrinol Metab 1991;75:1166.
9. Kupperman HS, Epstein JA. Medroxyprogesterone acetate in the treatment of costitutional sexual precocity. J Clin Endocrinol Metab 1962;22:456.
10. Feuillan PP, Foster CM, Peskowitz OH, Hench KD, Shawker T, Dwyer A, Malley JD, Barnes K, Loriaux DL, Cutler GB. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone. N Engl J Med 1986;315:1115.
11. Matarazzo P, de Sanctis U, Lala R. Peculiarità cliniche e terapeutiche della pubertà precoce in un caso di sindrome di McCune-Albright. Riv Ital Pediatr 1991;17:330.
12. Feuillan PP, Johns J, Cutler GB. Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome. J Clin Endocrinol Metab 1993;77:647.
13. Shenker A, Sweet DE, Spiegel AM, Weinstein LS. An activating Gs-alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome [Abstract]. J Bone Miner Research 1992;7(suppl I):S 115.
14. Oakhill A, Willshaw H, Mann JR. Unilateral proptosis. Arch Dis Child 1981;56:549.
15. Grant DB, Savage MO, Russel RGG. McCune-Albright syndrome with severe progressive polyostotic fibrous dysplasia. Failure of experimental treatment with salmon calcitonin and dichlorodiphosphonate. Pediatr Res 1982;16:899.
16. Raisz LG. Mechanisms and regulation of bone resorption by osteoclastic cells. In: Coe FL, Favus MJ, eds. Disorders of bone and mineral metabolism, New York: Raven Press 1992:287.
17. Liens D, Delmas P, Meunier PJ. Long term effects of intravenous pamidronate in fibrous dy splasia of bone. Lancet 1994;343:953.
18. Tanner JM, Witheouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity, weight velocity: British children, 1965. Part II. Arch Dis Child 1966;41:613.
19. Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist. Standford: Standford University Press 1959.
20. Breuer H, Hamel D, Kruskemper HL. Methods of hormone analysis. Stuttgart: G Thieme Verlag 1976.
21. Delmas PD. Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease. Endocrinol Metab Clin North Am 1990;19:1.
22. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. New Engl J Med 1991;325:1688.
23. Lee PA, Van Dop C, Migeon CJ. McCune-Albright syndrome. Long term follow-up. JAMA 1986;256:2980.
24. Ingrosso G, Pisano G., Lala R., Matarazzo P. Displasia fibrosa dello scheletro: recenti proposte terapeutiche. Atti del VI Congresso Nazionale della Società Italiana di Ortopedia e Traumatologia Pediatrica, Bellagio, 12-13 ottobre 1995.
25. van Persijn van Meerten EL, Kroon HM, Papapoulos SE. Epi- and metaphyseal changes in children caused by administration of bisphosphonates. Radiology 1992;184:249.
26. de Sanctis C, Bernasconi S, Buzi F, Cacciari E, Cisternino M, de Sanctis V, Pasquino AM, Rigon F, Saggese G. Studio multicentrico della sindrome di Mc Cune Albright. In: Atti del X Congresso Nazionale della S.I.E.D.P., Stresa 21-23 settembre 1995.